PANK2
Pantothenate kinase 2, mitochondrial
Also known as: C20orf48, FLJ11729, HARP, HSS, NBIA1, PANK2_HUMAN, PKAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZ23
- Gene
- PANK2
- Ensembl
- ENSG00000125779
- Chromosome
- 20
- Canonical length
- 570 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
570 residues, UniProt reviewed canonical sequence.
>Q9BZ23|PANK2
1 MRRLGPFHPR VHWAAPPSLS SGLHRLLFLR GTRIPSSTTL SPPRHDSLSL DGGTVNPPRV
61 REPTGREAFG PSPASSDWLP ARWRNGRGGR PRARLCSGWT AAEEARRNPT LGGLLGRQRL
121 LLRMGGGRLG APMERHGRAS ATSVSSAGEQ AAGDPEGRRQ EPLRRRASSA SVPAVGASAE
181 GTRRDRLGSY SGPTSVSRQR VESLRKKRPL FPWFGLDIGG TLVKLVYFEP KDITAEEEEE
241 EVESLKSIRK YLTSNVAYGS TGIRDVHLEL KDLTLCGRKG NLHFIRFPTH DMPAFIQMGR
301 DKNFSSLHTV FCATGGGAYK FEQDFLTIGD LQLCKLDELD CLIKGILYID SVGFNGRSQC
361 YYFENPADSE KCQKLPFDLK NPYPLLLVNI GSGVSILAVY SKDNYKRVTG TSLGGGTFFG
421 LCCLLTGCTT FEEALEMASR GDSTKVDKLV RDIYGGDYER FGLPGWAVAS SFGNMMSKEK
481 REAVSKEDLA RATLITITNN IGSIARMCAL NENINQVVFV GNFLRINTIA MRLLAYALDY
541 WSKGQLKALF SEHEGYFGAV GALLELLKIPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PANK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- testis: 24 nTPM
- choroid plexus: 23 nTPM
- tonsil: 21 nTPM
- bone marrow: 20 nTPM
- esophagus: 19 nTPM
- lymph node: 17 nTPM
Single-cell type
- esophageal apical cells: 429 nCPM
- neutrophils: 218 nCPM
- platelets: 154 nCPM
- epicardial cells: 148 nCPM
- kupffer cells: 145 nCPM
- late primary spermatocytes: 141 nCPM
Immune cell
- intermediate monocyte: 11 nTPM
- classical monocyte: 11 nTPM
- non-classical monocyte: 9.4 nTPM
- myeloid DC: 8.5 nTPM
- NK-cell: 6.8 nTPM
- neutrophil: 6.1 nTPM
Brain region
- hippocampal formation: 21 nTPM
- cerebellum: 20 nTPM
- cerebral cortex: 20 nTPM
- amygdala: 19 nTPM
- midbrain: 18 nTPM
- choroid plexus: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PANK2.
Disease | AllUniProt
Conditions PANK2 is implicated in, by any mechanism.
- Neurodegeneration with brain iron accumulation 1 (NBIA1) MIM:234200
Disease | GeneticClinVar
139 pathogenic / likely-pathogenic of 803 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pigmentary pallidal degeneration
- Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration
- Inborn genetic diseases
- Retinitis pigmentosa
- Neurodegeneration
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- angiogenesis
- coenzyme A biosynthetic process
- mitochondrion organization
- pantothenate metabolic process
- regulation of bile acid metabolic process
- regulation of fatty acid metabolic process
- regulation of mitochondrial membrane potential
- regulation of triglyceride metabolic process
- spermatid development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PANK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PANK2 as an antibody target. Whether an autoantibody or antibody against PANK2 could matter depends on whether native PANK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PANK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PANK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...